• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码RNA PCGEM1通过转化生长因子β2/Smad2信号通路调控口腔鳞状癌细胞侵袭和转移的机制

[Mechanism of long-chain noncoding RNA PCGEM1 in the regulation of the invasion and metastasis of oral squamous carcinoma cells via transforming growth factor β2/Smad2 signaling pathway].

作者信息

Weng Xu, Li Jin-Song, Fan Song

机构信息

Dept. of Stomatology, Shantou Central Hospital, Shantou 515031, China.

Dept. of Stomatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China.

出版信息

Hua Xi Kou Qiang Yi Xue Za Zhi. 2020 Oct 1;38(5):550-557. doi: 10.7518/hxkq.2020.05.014.

DOI:10.7518/hxkq.2020.05.014
PMID:33085241
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7573779/
Abstract

OBJECTIVE

To investigate the mechanism underlying the regulation of the invasion and metastasis of oral squamous cell carcinoma (OSCC) by long-chain noncoding RNA (lncRNA) PCGEM1 through the transforming growth factor (TGF) β2/Smad2 signaling pathways.

METHODS

A total of 60 OSCC cases were collected. Cancer tissues and normal tissues more than 2 cm away from cancer tissues were also collected. Real-time quantitative polymerase chain reaction (qRT-PCR) was used to detect the expression of miR-148a and lncRNA PCGEM1 in OSCC, adjacent normal tissues, oral mucosa epithelial cells, KB, BcaCD885, SCC-4, CAL27, and SCC-15. The relationship between the expression of lncRNA PCGEM1 and miR-148a and the clinicopathological information of patients was analyzed. The lncRNA PCGEM1-silenced cell line KB-siPCGEM1 and negative control (KB-NC) group were constructed, and KB was used as the blank control group. The effects of lncRNA PCGEM1 on the proliferation, invasion, and migration of KB cells were determined via MTT, Transwell, and scratch assays. The bioinformatics website starBase was used to predict the complementary binding microRNA (miRNA) of lncRNA PCGEM1. Furthermore, the genes that the miRNA could target and bind were predicted in accordance with the website www.microRNA.org. Western blotting analysis was used to detect the expression of TGF β2/Smad2 signaling pathway proteins.

RESULTS

qRT-PCR results showed that the expression level of lncRNA PCGEM1 and miR-148a in OSCC tissues was higher than that in normal tissues (P<0.05). The expression of lncRNA PCGEM1 and miR-148a in the cancer tissues of patients with different TNM grades, lymph node metastasis, and tissue differentiation was statistically significant (P<0.05). Compared with those in the blank control group and the KB-NC group, OD492 nm value was significantly decreased and cell mobility was significantly reduced in the KB-siPCGEM1 group (P<0.05). Bioinformatics predictions showed that lncRNA PCGEM1 could bind to miR-148a in a complementary manner and that miR-148a had a targeted binding site with TGF β2. qRT-PCR and Western blotting analysis results showed that the expression levels of miR-148a, TGF β2, and p-Smad2 in the KB-siPCGEM1 group were significantly lower than those in the blank control and KB-NC groups (P<0.05), and no statistically significant difference between the blank control group and the KB-NC group was observed (P>0.05).

CONCLUSIONS

LncRNA PCGEM1 is highly expressed in OSCC. The high expression of lncRNA PCGEM1 may enhance the TGF β2/Smad2 signaling pathway by upregulating miR-148a, thus promoting the development of OSCC.

摘要

目的

探讨长链非编码RNA(lncRNA)PCGEM1通过转化生长因子(TGF)β2/Smad2信号通路调控口腔鳞状细胞癌(OSCC)侵袭和转移的机制。

方法

收集60例OSCC病例,同时收集癌组织及距癌组织2 cm以外的正常组织。采用实时定量聚合酶链反应(qRT-PCR)检测miR-148a和lncRNA PCGEM1在OSCC组织、癌旁正常组织、口腔黏膜上皮细胞、KB、BcaCD885、SCC-4、CAL27和SCC-15中的表达。分析lncRNA PCGEM1和miR-148a的表达与患者临床病理信息的关系。构建lncRNA PCGEM1沉默细胞系KB-siPCGEM1和阴性对照组(KB-NC),以KB作为空白对照组。通过MTT法、Transwell法和划痕实验检测lncRNA PCGEM1对KB细胞增殖、侵袭和迁移的影响。利用生物信息学网站starBase预测lncRNA PCGEM1的互补结合微小RNA(miRNA),并根据网站www.microRNA.org预测该miRNA可能靶向结合的基因。采用蛋白质印迹法检测TGF β2/Smad2信号通路蛋白的表达。

结果

qRT-PCR结果显示,lncRNA PCGEM1和miR-148a在OSCC组织中的表达水平高于正常组织(P<0.05)。lncRNA PCGEM1和miR-148a在不同TNM分级、有淋巴结转移及组织分化程度的患者癌组织中的表达差异有统计学意义(P<0.05)。与空白对照组和KB-NC组相比,KB-siPCGEM1组的OD492 nm值显著降低,细胞迁移能力显著降低(P<0.05)。生物信息学预测显示,lncRNA PCGEM1可与miR-148a互补结合,且miR-148a与TGF β2有靶向结合位点。qRT-PCR和蛋白质印迹法分析结果显示,KB-siPCGEM1组中miR-148a、TGF β2和p-Smad2的表达水平显著低于空白对照组和KB-NC组(P<0.05),空白对照组和KB-NC组之间差异无统计学意义(P>0.05)。

结论

lncRNA PCGEM1在OSCC中高表达。lncRNA PCGEM1的高表达可能通过上调miR-148a增强TGF β2/Smad2信号通路,从而促进OSCC的发展。

相似文献

1
[Mechanism of long-chain noncoding RNA PCGEM1 in the regulation of the invasion and metastasis of oral squamous carcinoma cells via transforming growth factor β2/Smad2 signaling pathway].长链非编码RNA PCGEM1通过转化生长因子β2/Smad2信号通路调控口腔鳞状癌细胞侵袭和转移的机制
Hua Xi Kou Qiang Yi Xue Za Zhi. 2020 Oct 1;38(5):550-557. doi: 10.7518/hxkq.2020.05.014.
2
MiR-148a inhibits oral squamous cell carcinoma progression through ERK/MAPK pathway via targeting IGF-IR.miR-148a 通过靶向 IGF-IR 抑制 ERK/MAPK 通路抑制口腔鳞状细胞癌进展。
Biosci Rep. 2020 Apr 30;40(4). doi: 10.1042/BSR20182458.
3
Long noncoding RNA SNHG20 regulates cell migration, invasion, and proliferation via the microRNA-19b-3p/RAB14 axis in oral squamous cell carcinoma.长链非编码 RNA SNHG20 通过 microRNA-19b-3p/RAB14 轴调控口腔鳞状细胞癌中的细胞迁移、侵袭和增殖。
Bioengineered. 2021 Dec;12(1):3993-4003. doi: 10.1080/21655979.2021.1950278.
4
[Effect of circular RNA hsa_circ_0008898 on oral squamous cell carcinoma and its mechanism].[环状RNA hsa_circ_0008898对口腔鳞状细胞癌的影响及其机制]
Zhonghua Kou Qiang Yi Xue Za Zhi. 2020 Aug 9;55(8):578-585. doi: 10.3760/cma.j.cn112144-20200109-00006.
5
Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.长链非编码 RNA CCAT1 通过 miR-181a 介导的 Wnt/β-catenin 信号通路促进口腔鳞状细胞癌的进展,是其预后的生物标志物。
Cell Cycle. 2019 Nov;18(21):2902-2913. doi: 10.1080/15384101.2019.1662257. Epub 2019 Sep 4.
6
MicroRNA-148a-3p inhibits progression of hepatocelluar carcimoma by repressing SMAD2 expression in an Ago2 dependent manner.microRNA-148a-3p 通过依赖于 Ago2 的方式抑制 SMAD2 表达抑制肝癌细胞的进展。
J Exp Clin Cancer Res. 2020 Aug 4;39(1):150. doi: 10.1186/s13046-020-01649-0.
7
Expression and mechanism of long non-coding RNA HCG22 in oral squamous cell carcinoma.长链非编码 RNA HCG22 在口腔鳞状细胞癌中的表达及机制。
Hua Xi Kou Qiang Yi Xue Za Zhi. 2021 Dec 1;39(6):658-666. doi: 10.7518/hxkq.2021.06.006.
8
Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.lncRNA FEZF1-AS1 通过靶向 miR-196a 促进口腔鳞状细胞癌发生发展的机制。
Eur Rev Med Pharmacol Sci. 2019 Aug;23(15):6505-6515. doi: 10.26355/eurrev_201908_18534.
9
LncRNA MCM3AP-AS1 promotes proliferation, migration and invasion of oral squamous cell carcinoma cells via regulating miR-204-5p/FOXC1.长链非编码 RNA MCM3AP-AS1 通过调节 miR-204-5p/FOXC1 促进口腔鳞状细胞癌细胞的增殖、迁移和侵袭。
J Investig Med. 2020 Oct;68(7):1282-1288. doi: 10.1136/jim-2020-001415. Epub 2020 Jul 19.
10
PCGEM1 promotes proliferation, migration and invasion in prostate cancer by sponging miR-506 to upregulate TRIAP1.PCGEM1 通过海绵吸附 miR-506 来上调 TRIAP1 促进前列腺癌的增殖、迁移和侵袭。
BMC Urol. 2022 Feb 2;22(1):14. doi: 10.1186/s12894-022-00969-x.

引用本文的文献

1
miR-379-5p regulates the proliferation, cell cycle, and cisplatin resistance of oral squamous cell carcinoma cells by targeting ROR1.微小RNA-379-5p通过靶向ROR1调控口腔鳞状细胞癌细胞的增殖、细胞周期及顺铂耐药性。
Am J Transl Res. 2023 Mar 15;15(3):1626-1639. eCollection 2023.
2
LncRNA PCGEM1 in Human Cancers: Functions, Mechanisms and Promising Clinical Utility.人癌症中的长链非编码RNA PCGEM1:功能、机制及潜在临床应用
Front Oncol. 2022 Feb 21;12:847745. doi: 10.3389/fonc.2022.847745. eCollection 2022.

本文引用的文献

1
Hypoxia-induced LncRNA PCGEM1 promotes invasion and metastasis of gastric cancer through regulating SNAI1.缺氧诱导的长链非编码 RNA PCGEM1 通过调节 SNAI1 促进胃癌的侵袭和转移。
Clin Transl Oncol. 2019 Sep;21(9):1142-1151. doi: 10.1007/s12094-019-02035-9. Epub 2019 Jan 28.
2
Fucosyltransferase 2 induced epithelial-mesenchymal transition via TGF-β/Smad signaling pathway in lung adenocarcinaoma.岩藻糖基转移酶 2 通过 TGF-β/Smad 信号通路诱导肺腺癌上皮-间质转化。
Exp Cell Res. 2018 Sep 15;370(2):613-622. doi: 10.1016/j.yexcr.2018.07.026. Epub 2018 Jul 18.
3
LncRNA PCGEM1 Induces Ovarian Carcinoma Tumorigenesis and Progression Through RhoA Pathway.长链非编码RNA PCGEM1通过RhoA信号通路诱导卵巢癌的发生和进展。
Cell Physiol Biochem. 2018;47(4):1578-1588. doi: 10.1159/000490931. Epub 2018 Jun 27.
4
miR-148a-3p suppresses epithelial ovarian cancer progression primarily by targeting c-Met.微小RNA-148a-3p主要通过靶向c-Met抑制上皮性卵巢癌进展。
Oncol Lett. 2018 May;15(5):6131-6136. doi: 10.3892/ol.2018.8110. Epub 2018 Feb 23.
5
Nkx2.8 Inhibits Epithelial-Mesenchymal Transition in Bladder Urothelial Carcinoma via Transcriptional Repression of .NKX2.8 通过转录抑制 抑制膀胱尿路上皮癌中的上皮-间质转化。
Cancer Res. 2018 Mar 1;78(5):1241-1252. doi: 10.1158/0008-5472.CAN-17-1545. Epub 2018 Jan 8.
6
HMGA2 facilitates epithelial-mesenchymal transition in renal cell carcinoma by regulating the TGF-β/Smad2 signaling pathway.HMGA2 通过调节 TGF-β/Smad2 信号通路促进肾细胞癌的上皮-间充质转化。
Oncol Rep. 2018 Jan;39(1):101-108. doi: 10.3892/or.2017.6091. Epub 2017 Nov 10.
7
MicroRNA-148a-3p enhances cisplatin cytotoxicity in gastric cancer through mitochondrial fission induction and cyto-protective autophagy suppression.微小RNA-148a-3p通过诱导线粒体分裂和抑制细胞保护性自噬增强顺铂对胃癌的细胞毒性。
Cancer Lett. 2017 Dec 1;410:212-227. doi: 10.1016/j.canlet.2017.09.035. Epub 2017 Sep 28.
8
Plasmacytoid Urothelial Carcinoma of the Urinary Bladder: A Clinicopathologic and Immunohistochemical Analysis of 49 Cases.膀胱浆细胞样尿路上皮癌:49例临床病理及免疫组化分析
Am J Clin Pathol. 2017 May 1;147(5):500-506. doi: 10.1093/ajcp/aqx029.
9
Cathepsin K modulates invasion, migration and adhesion of oral squamous cell carcinomas in vitro.组织蛋白酶K在体外调节口腔鳞状细胞癌的侵袭、迁移和黏附。
Oral Dis. 2017 May;23(4):518-525. doi: 10.1111/odi.12643. Epub 2017 Mar 9.
10
Pyropia yezoensis peptide promotes collagen synthesis by activating the TGF-β/Smad signaling pathway in the human dermal fibroblast cell line Hs27.条斑紫菜肽通过激活人皮肤成纤维细胞系Hs27中的TGF-β/Smad信号通路促进胶原蛋白合成。
Int J Mol Med. 2017 Jan;39(1):31-38. doi: 10.3892/ijmm.2016.2807. Epub 2016 Nov 18.